Reciprocal regulation of p21 and Chk1 controls the cyclin D1-RB pathway to mediate senescence onset after G2 arrest

Area of Science:

• Cell Biology
• Molecular Biology
• Cancer Research

Background:

• Senescence prevents genomic instability following DNA damage by causing irreversible cell cycle arrest.
• The precise molecular mechanisms regulating the transition from transient G2 arrest to permanent senescence are not fully understood.
• Tumor suppressors p53 (TP53) and retinoblastoma protein (RB1) are known to be critical for G2 senescence onset.

Purpose of the Study:

• To elucidate the regulatory network controlling G2 arrest exit and senescence induction after DNA damage.
• To investigate the roles of p21, Chk1, and RB in managing cell cycle progression during G2 arrest.
• To identify key factors that determine whether cells undergo senescence or genome reduplication.

Main Methods:

• Utilized non-transformed and cancer cell lines.
• Performed experiments involving knockdown of checkpoint kinases (Chk1, Chk2).
• Analyzed protein interactions and activity, including cyclin-dependent kinase (CDK) inhibitors, checkpoint kinases, and tumor suppressors.

Main Results:

• A novel balance between p21 and Chk1 regulates cyclin D-CDK activity during G2 arrest.
• In non-transformed cells, p21 activates RB, promoting G2 exit, Chk1 downregulation, and reduced DNA damage foci.
• In cancer cells, sustained Chk1 activity and delayed p21 induction impair G2 exit, leading to genome reduplication; Chk1 depletion or Chk2 knockdown promotes senescence.

Conclusions:

• p21 and Chk2 act antagonistically to Chk1, maintaining RB activity to promote DNA damage-induced senescence in G2.
• Dysregulation of the p21-Chk1-RB axis contributes to genomic instability in cancer cells.
• Understanding this regulatory balance offers potential therapeutic targets for cancer treatment.